Avaí Bio, Inc.
AVAI
$0.17
-$0.02-8.81%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -82.04% | 38.16% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -332.50% | -24.66% | |||
| Total Operating Expenses | -102.55% | 22.23% | |||
| Operating Income | 102.55% | -22.23% | |||
| Income Before Tax | 53.91% | -22.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 53.91% | -22.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 53.91% | -22.23% | |||
| EBIT | 102.55% | -22.23% | |||
| EBITDA | 103.78% | -22.55% | |||
| EPS Basic | 55.00% | -21.21% | |||
| Normalized Basic EPS | 56.00% | -19.05% | |||
| EPS Diluted | 55.00% | -21.21% | |||
| Normalized Diluted EPS | 56.00% | -19.05% | |||
| Average Basic Shares Outstanding | 0.54% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.54% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||